Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction

Journal of the American College of Cardiology

Volumn 39, Issue 11, 2002, Pages 1733-1737

  Zijlstra, Felix ^a   Ernst, Nicolette ^a   De Boer, Menko Jan ^a   Nibbering, Edwin ^a   Suryapranata, Harry ^a   Hoorntje, Jan C A ^a   Dambrink, Jan Henk E ^a   Van'T Hof, Arnoud W J ^a   Verheugt, Freek W A ^b  

^a HOSPITAL DE WEEZENLANDEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT TRANSPORT; PRIORITY JOURNAL; RISK ASSESSMENT; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CORONARY ANGIOGRAPHY; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 0037024208     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)01856-9     Document Type: Article

References (20)

1. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review
2. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction
3. Coronary disease: Acute myocardial infarction: Primary angioplasty
4. Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction
5. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT trial
6. High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction: Results of the Heparin in Early Patency (HEAP) pilot study
7. High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: The Heparin in Early Patency (HEAP) randomized trial
8. Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty: Results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) pilot study
9. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction
10. Effects of intracoronary streptokinase on infarct size estimated from cumulative enzyme release and on enzyme release rate: A randomised trial of 533 patients with acute myocardial infarction
11. Enzyme tests in the evaluation of thrombolysis in acute myocardial infarction
12. Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy
13. Use and effectiveness of intravenous heparin therapy for treatment of acute myocardial infarction in the elderly
14. Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: Results of a randomised double blind European Cooperative study group trial
15. An international randomised trial comparing four thrombolytic strategies for acute myocardial infarction
16. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
17. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction
18. Transferring patients for primary angioplasty: A retrospective analysis of 104 selected high risk patients with acute myocardial infarction
19. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction
20. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction